Dr. Russomanno is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
80 Seymour Street
Hartford, CT 06106Phone+1 860-972-0001
Education & Training
- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1988 - 1991
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1985 - 1988
- Rutgers Robert Wood Johnson Medical SchoolClass of 1985
Certifications & Licensure
- CT State Medical License 1991 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Publications & Presentations
PubMed
- 72 citationsPhase I, open-label, safety and pharmacokinetic study to assess bronchopulmonary disposition of intravenous eravacycline in healthy men and women.Kevin P. Connors, Seth T. Housman, J. Samuel Pope, John Russomanno, Edward Salerno
Antimicrobial Agents and Chemotherapy. 2014-04-01 - 42 citationsBronchopulmonary Disposition of Intravenous Voriconazole and Anidulafungin Given in Combination to Healthy AdultsJared L. Crandon, Mary Anne Banevicius, Annie F. Fang, Penelope Crownover, R. Fredrick Knauft
Antimicrobial Agents and Chemotherapy. 2009-12-01 - 23 citationsBronchopulmonary Disposition of Micafungin in Healthy Adult VolunteersAnthony M. Nicasio, Pamela R. Tessier, David P. Nicolau, R. Fredrick Knauft, John Russomanno
Antimicrobial Agents and Chemotherapy. 2009-03-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: